Covidien’s Pipeline Gains Unanimous Panel Endorsement For Large Aneurysms
FDA’s Neurological Devices Panel unanimously endorsed safety and efficacy data on Covidien’s Pipeline aneurysm embolization device March 18.
More from Archive
More from Medtech Insight
• By
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
• By
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
• By
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.